中文
中文

Core Business

CORE BUSINESS

Centered on biological products, the company operates six business segments — biologics, vaccines, blood products, cell therapy, diagnostic reagents and medical services — forming a complete chain from R&D to the end user.

  • Biologics

    A complete antibody drug industry chain, together with a distinctive large-scale molecular diagnostics chain.

  • Vaccines

    Covering both immunization program and non-program vaccines, a full-chain quality system ensures safety and efficacy.

  • Blood Products

    A complete industry chain from plasma collection and separation/purification to finished dosage forms, ensuring a stable supply of blood products for clinical use.

  • Cell Therapy

    Focusing on CAR-T and stem cell therapy, the company advances the clinical translation of precision treatments.

  • Diagnostics

    Developing molecular and immuno-diagnostic products to form an integrated package of reagents and instruments.

  • Medical Services

    Backed by a nationwide cold-chain distribution network, the company provides timely and stable supply services for pharmaceuticals and vaccines.